Clinical Trial Update: Anti-proliferative Effects of Vitamin D and Melatonin in Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the anti-proliferative effects of vitamin D and melatonin in early stage breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Melatonin (melatonin)
• Vitamin D (Cholecalciferol)

Snippet

Sponsor: Juravinski Cancer Center | Conditions: Early Stage Breast Cancer | Phase 2 | Status: COMPLETED